Funded Biotech startups in Pennsylvania
13 biotech startups in Pennsylvania have filed a Form D with the SEC and together report $116M raised. Fore Biotherapeutics has the largest latest round, at $70.4M. Amounts are as reported on the filing, not estimates.
Updated Sep 1, 2026
- Companies
- 13
- Total raised
- $116.0M
- Filings
- 18
- Median round
- $1.0M
- Cities
- 9
CompanyCityLast filingLatest round
Myris TherapeuticsHigh-payload antibody drug conjugates for cancer
Sharpsburg
Sep 1, 2026
$500K
Tolerance BioStem cell-derived thymus therapies for immune tolerance
Philadelphia
Jun 3, 2026
$15.1M
BioLattice OphthalmicsSynthetic cornea implant to replace donor tissue
Philadelphia
Mar 6, 2026
$575K
NK-One TherapeuticsSpinal injection therapy for intractable cancer pain
Wayne
Mar 4, 2026
$290K
Mussel PolymersMussel-inspired adhesive that bonds underwater
Bethlehem
Dec 31, 2025
$4.8M
Aethl BioOxygen-delivering hydrogels for chronic wound care
Pittsburgh
Jul 14, 2025
$1.6M
Fore BiotherapeuticsBRAF inhibitor for brain and solid tumors
Philadelphia
Apr 30, 2025
$70.4M
IllexcorOral drug for sickle cell disease
Henrico
Mar 8, 2025
$1.0M
BobcatBioCancer-specific T cell therapies
Hummelstown
Feb 26, 2025
$5.3M
Nok TherapeuticsNatural killer cell therapy for myeloma and bladder cancer
Cranberry Twp.
Sep 24, 2024
$751K
Jabez BiosciencesOral pyrimidine-blocking drug for solid and blood cancers
Cranberry Twp.
Jun 11, 2024
$31K
Chimeron BioSelf-amplifying RNA medicines and vaccines
Philadelphia
Mar 25, 2024
$12.8M
Contamination Source IdentificationRNA sequencing test that identifies active infections
Hershey
Apr 19, 2023
$2.1M
All 13 companies · most recent filing first
Most recent filings
13All 13 companies · most recent filing first